ST Pharm Co.,Ltd. (KOSDAQ:237690)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Raw Material Manufacturing			251.56B	209.27B	139.14B	109.05B	-
Raw Material Manufacturing Growth			20.21%	50.40%	27.59%	-	-
Clinical Trial Contract Research			33.76B	40.32B	27.16B	15.12B	-
Clinical Trial Contract Research Growth			-16.26%	48.46%	79.66%	-	-
Consolidation Adjustment			-326.10M	-263.41M	-652.92M	-55.97M	-
Manufacture and Sell New and Generic Raw Drug Products			-	-	-	-	93.26B
Manufacture and Sell New and Generic Raw Drug Products Growth			-	-	-	-	-4.59%
Total			284.99B	249.32B	165.64B	124.11B	93.26B
Total Growth			14.31%	50.52%	33.47%	33.08%	-4.59%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Korea			39.84B	52.57B	45.47B	44.46B	47.27B
Korea Growth			-24.22%	15.61%	2.28%	-5.94%	45.21%
Switzerland			98.64B	110.25B	61.81B	26.87B	-
Switzerland Growth			-10.53%	78.39%	129.98%	-	-
USA			51.95B	30.31B	22.52B	20.12B	-
USA Growth			71.42%	34.60%	11.90%	-	-
Other Countries			66.28B	55.54B	35.85B	29.57B	-
Other Countries Growth			19.34%	54.92%	21.22%	-	-
Belgium			28.28B	658.69M	-	-	-
Belgium Growth			4194.11%	-	-	-	-
Spain			-	-	-	3.08B	-
Export			-	-	-	-	45.99B
Export Growth			-	-	-	-	-29.45%
Total			284.99B	249.32B	165.64B	124.11B	93.26B
Total Growth			14.31%	50.52%	33.47%	33.08%	-4.59%

Source: S&P Global Market Intelligence.